{"cluster": 26, "subcluster": 14, "abstract_summ": " The coronavirus disease 2019 (COVID-19) pandemic has introduced a major disruption to the delivery of routine health care across the world . This provides challenges for the use of secondary prevention measures in patients with established atherosclerotic cardiovascular disease (CVD)"}